Extendicare Inc. (TSE:EXE – Get Free Report)’s share price hit a new 52-week high on Tuesday . The stock traded as high as C$9.52 and last traded at C$9.50, with a volume of 47685 shares. The stock had previously closed at C$9.48.
Analysts Set New Price Targets
Several research analysts have commented on EXE shares. TD Securities lifted their target price on Extendicare from C$9.00 to C$9.50 and gave the stock a “hold” rating in a report on Wednesday, September 4th. Royal Bank of Canada increased their target price on shares of Extendicare from C$8.50 to C$9.50 in a research report on Monday, August 19th.
Check Out Our Latest Stock Analysis on EXE
Extendicare Stock Performance
Extendicare (TSE:EXE – Get Free Report) last issued its quarterly earnings results on Monday, August 12th. The company reported C$0.29 earnings per share for the quarter. Extendicare had a net margin of 4.28% and a return on equity of 60.00%. The company had revenue of C$348.48 million for the quarter, compared to the consensus estimate of C$360.20 million. As a group, sell-side analysts expect that Extendicare Inc. will post 0.6134729 EPS for the current fiscal year.
Extendicare Dividend Announcement
The business also recently declared a monthly dividend, which will be paid on Tuesday, October 15th. Investors of record on Monday, September 30th will be issued a $0.04 dividend. The ex-dividend date is Friday, September 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 5.08%. Extendicare’s dividend payout ratio (DPR) is presently 70.59%.
Extendicare Company Profile
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Read More
- Five stocks we like better than Extendicare
- ESG Stocks, What Investors Should Know
- Why Lennar Stock Could Be the Best Play in the Housing Market
- P/E Ratio Calculation: How to Assess Stocks
- 2 Energy Stocks Fueling the AI Datacenter Boom
- There Are Different Types of Stock To Invest In
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.